Repligen (RGEN) Misses Q2 EPS by 2c; offers guidance

Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.37, $0.02 worse than the analyst estimate of $0.39. Revenue for the quarter came in at $182 million versus the consensus estimate of $175.35 million.

GUIDANCE:

Repligen sees FY2025 EPS of $1.65-$1.72, versus the consensus of $1.68. Repligen sees FY2025 revenue of $715-735 million, versus the consensus of $710.2 million.

For earnings history and earnings-related data on Repligen (RGEN) click here.

You May Also Be Interested In

• Apple announced foldable iPhone Duo, starting at $1,999
• Chewy (CHWY) Reports In-Line Q2 EPS, Offers Guidance
• Signet Jewelers (SIG) Tops Q2 EPS by 47c, Misses on Revenue; Offers FY27 Guidance